Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × abivertinib × Clear all

NCT05361915 2024-03-18

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Phase 2 Suspended

Prostatic Neoplasms